2:1 (or international equivalent) in a relevant subject.
Months of entry
January, December, November, October, September, August, July, June, May, April, March, February
Research in this division is directed towards understanding molecular basis of disease including allergy, auto-immunity and cancer. In particular research is being carried out into immunological diseases such as asthma, psoriasis, and type 1 diabetes and leukaemias including acute myeloid leukaemia, chronic lymphocytic leukaemia and non-Hodgkins lymphoma. In the long term this research is aimed at identifying new targets for these diseases. Approaches used to reach these goals include metabolomic studies at both a cellular and whole body level and the use of post genomic technologies (including cDNA microarray) and systems biology applications to investigate the control of gene expression.
More than £9 million has gone into state-of-the-art laboratory facilities and equipment, which are housed in the modern Boots Science Building and the £25 million Centre for Biomolecular Sciences. The latter is the University’s largest and most ambitious research structure, bringing together some 300 scientists from across the University, including our Division of Medicinal Chemistry and Structural Biology and part of our Division of Molecular and Cellular Science.
For a more extensive overview, please visit the course page on the University of Nottingham's online prospectus.
Information for international students
English language requirements: IELTS 7.0 (no less than 6.0 in any element) for clinical projects and 6.0 (no less than 5.5 in any element) for science projects.
Fees and funding
The Graduate School at The University of Nottingham provides information on internal and external sources of postgraduate funding.
There is also funding information on the School of Pharmacy web pages.
For information on funding opportunities for international students, please see the International Office website.
Qualification and course duration
Course contact details
- Professor David Heery
- +44 (0)115 951 5087